Rallybio Corp Company Insiders
RLYB Stock | USD 1.14 0.06 5.00% |
About 60% of all Rallybio Corp's insiders are taking a long position. The analysis of the overall insider sentiment regarding Rallybio Corp suggests that some insiders are bullish. Rallybio Corp employs about 43 people. The company is managed by 6 executives with a total tenure of roughly 101 years, averaging almost 16.0 years of service per executive, having 7.17 employees per reported executive.
Rallybio Corp's Insider Buying Vs Selling
60
Selling | Buying |
Latest Trades
2023-03-14 | Jonathan I Lieber | Acquired 5000 @ 5.21 | View | ||
2023-03-07 | Kush Parmar | Disposed 100000 @ 8.2 | View | ||
2022-06-03 | Kush Parmar | Disposed 150000 @ 12.5 | View | ||
2022-05-23 | Kush Parmar | Disposed 100000 @ 13 | View | ||
2022-03-21 | Jeffrey M Fryer | Acquired 3000 @ 8.04 | View | ||
2022-02-08 | Opportunities I L.P. 5Am | Disposed 210000 @ 13.05 | View | ||
2022-01-19 | Jeffrey M Fryer | Acquired 1400 @ 8.7 | View | ||
2022-01-12 | Stephen Uden | Acquired 5000 @ 10.55 | View | ||
2022-01-10 | Martin Mackay | Acquired 5504 @ 10.1 | View | ||
2022-01-07 | Jeffrey M Fryer | Acquired 10000 @ 9.41 | View |
Monitoring Rallybio Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Rallybio |
Rallybio Corp Management Team Effectiveness
The company has return on total asset (ROA) of (0.3854) % which means that it has lost $0.3854 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6739) %, meaning that it created substantial loss on money invested by shareholders. Rallybio Corp's management efficiency ratios could be used to measure how well Rallybio Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of December 12, 2024, Return On Tangible Assets is expected to decline to -0.68. In addition to that, Return On Capital Employed is expected to decline to -0.78. At present, Rallybio Corp's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 204.5 M, whereas Return On Tangible Assets are forecasted to decline to (0.68).As of December 12, 2024, Common Stock Shares Outstanding is expected to decline to about 37.1 M. In addition to that, Net Loss is expected to decline to about (63 M)
Rallybio Corp Workforce Comparison
Rallybio Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,230. Rallybio Corp holds roughly 43.0 in number of employees claiming about 4% of equities under Health Care industry.
Rallybio Corp Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rallybio Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rallybio Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Rallybio Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Uden Stephen few days ago Acquisition by Uden Stephen of 62000 shares of Rallybio Corp at 15.04 subject to Rule 16b-3 | ||
Nash Christine A over two weeks ago Acquisition by Nash Christine A of 15490 shares of Rallybio Corp at 5.64 subject to Rule 16b-3 | ||
Hunt Ronald over a month ago Acquisition by Hunt Ronald of 16500 shares of Rallybio Corp at 1.91 subject to Rule 16b-3 | ||
Ryder Steven over three months ago Acquisition by Ryder Steven of 119000 shares of Rallybio Corp at 6.5 subject to Rule 16b-3 | ||
Ryder Steven over three months ago Acquisition by Ryder Steven of 120000 shares of Rallybio Corp at 1.86 subject to Rule 16b-3 | ||
Lieber Jonathan I over six months ago Acquisition by Lieber Jonathan I of 120000 shares of Rallybio Corp subject to Rule 16b-3 | ||
Ryder Steven over six months ago Acquisition by Ryder Steven of 120000 shares of Rallybio Corp at 1.86 subject to Rule 16b-3 | ||
Viking Global Investors Lp over six months ago Purchase by Viking Global Investors Lp of 3333388 shares of Rallybio Corp |
Rallybio Corp Notable Stakeholders
A Rallybio Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Rallybio Corp often face trade-offs trying to please all of them. Rallybio Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Rallybio Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Martin MacKay | CoFounder Chairman | Profile | |
MD MB | President, CoFounder | Profile | |
Jonathan MBA | CFO Treasurer | Profile | |
Ami Bavishi | Head Communications | Profile | |
Jeffrey CPA | CFO CoFounder | Profile | |
MD FACP | Chief Officer | Profile |
About Rallybio Corp Management Performance
The success or failure of an entity such as Rallybio Corp often depends on how effective the management is. Rallybio Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Rallybio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Rallybio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.64) | (0.68) | |
Return On Capital Employed | (0.74) | (0.78) | |
Return On Assets | (0.64) | (0.68) | |
Return On Equity | (0.70) | (0.67) |
Please note, the presentation of Rallybio Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Rallybio Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Rallybio Corp's management manipulating its earnings.
Rallybio Corp Workforce Analysis
Traditionally, organizations such as Rallybio Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Rallybio Corp within its industry.Rallybio Corp Manpower Efficiency
Return on Rallybio Corp Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.7M | |
Net Loss Per Executive | 12.4M | |
Working Capital Per Employee | 2.5M | |
Working Capital Per Executive | 17.6M |
Complementary Tools for Rallybio Stock analysis
When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stocks Directory Find actively traded stocks across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |